• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上下文依赖的表观遗传和器官发生程序决定了MYC驱动的小鼠肝癌细胞的三维与二维细胞适应性。

The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven murine liver cancer cells.

作者信息

Fang Jie, Singh Shivendra, Wells Brennan, Wu Qiong, Jin Hongjian, Janke Laura J, Wan Shibiao, Steele Jacob A, Connelly Jon P, Murphy Andrew J, Wang Ruoning, Davidoff Andrew, Ashcroft Margaret, Pruett-Miller Shondra M, Yang Jun

机构信息

Department of Surgery, St Jude Children's Research Hospital, Memphis, United States.

Center for Applied Bioinformatics, St Jude Children's Research Hospital, Memphis, United States.

出版信息

Elife. 2025 May 6;14:RP101299. doi: 10.7554/eLife.101299.

DOI:10.7554/eLife.101299
PMID:40326560
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12055005/
Abstract

3D cellular-specific epigenetic and transcriptomic reprogramming is critical to organogenesis and tumorigenesis. Here, we dissect the distinct cell fitness in 2D (normoxia vs. chronic hypoxia) vs 3D (normoxia) culture conditions for an MYC-driven murine liver cancer model. We identify over 600 shared essential genes and additional context-specific fitness genes and pathways. Knockout of the VHL-HIF1 pathway results in incompatible fitness defects under normoxia vs. 1% oxygen or 3D culture conditions. Moreover, deletion of each of the mitochondrial respiratory electron transport chain complex has distinct fitness outcomes. Notably, multicellular organogenesis signaling pathways including TGFβ-SMAD, which is upregulated in 3D culture, specifically constrict the uncontrolled cell proliferation in 3D while inactivation of epigenetic modifiers (, , and ) has opposite outcomes in 2D vs. 3D. We further identify a 3D-dependent synthetic lethality with partial loss of due to a reduction of expression resulting from 3D-specific epigenetic reprogramming. Our study highlights unique epigenetic, metabolic, and organogenesis signaling dependencies under different cellular settings.

摘要

3D细胞特异性表观遗传和转录组重编程对于器官发生和肿瘤发生至关重要。在此,我们剖析了MYC驱动的小鼠肝癌模型在2D(常氧与慢性缺氧)与3D(常氧)培养条件下不同的细胞适应性。我们鉴定出600多个共享的必需基因以及其他特定背景的适应性基因和途径。在常氧与1%氧气或3D培养条件下,VHL - HIF1途径的敲除导致不相容的适应性缺陷。此外,线粒体呼吸电子传递链复合物中每个复合物的缺失都有不同的适应性结果。值得注意的是,包括TGFβ - SMAD在内的多细胞器官发生信号通路在3D培养中上调,在3D中特异性限制不受控制的细胞增殖,而表观遗传修饰因子(、、和)的失活在2D与3D中有相反的结果。我们进一步鉴定出由于3D特异性表观遗传重编程导致表达降低而与部分缺失相关的3D依赖性合成致死性。我们的研究突出了不同细胞环境下独特的表观遗传、代谢和器官发生信号依赖性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/66e1c1a4bc83/elife-101299-fig7-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/f716f75b7796/elife-101299-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/20179a54c04e/elife-101299-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/dc20a00495ae/elife-101299-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/1724d1d58cac/elife-101299-fig1-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/bd0ec7990111/elife-101299-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/28ed3eb9f774/elife-101299-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/e3b206582ad3/elife-101299-fig2-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/4e3c9ff7b09f/elife-101299-fig2-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/b504bb4e34fd/elife-101299-fig2-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/80f52e2ee468/elife-101299-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/42adbcf482a5/elife-101299-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/2b4b56f4176d/elife-101299-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/b20e4644e839/elife-101299-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/87c7354db015/elife-101299-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/684c90a89132/elife-101299-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/a3e22dad0e6f/elife-101299-fig5-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/38af8f2aa601/elife-101299-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/1bf4ac49fe63/elife-101299-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/d3b3a90a1926/elife-101299-fig6-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/8b11b64a9744/elife-101299-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/4a170e04b391/elife-101299-fig7-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/05f7f4682930/elife-101299-fig7-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/66e1c1a4bc83/elife-101299-fig7-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/f716f75b7796/elife-101299-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/20179a54c04e/elife-101299-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/dc20a00495ae/elife-101299-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/1724d1d58cac/elife-101299-fig1-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/bd0ec7990111/elife-101299-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/28ed3eb9f774/elife-101299-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/e3b206582ad3/elife-101299-fig2-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/4e3c9ff7b09f/elife-101299-fig2-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/b504bb4e34fd/elife-101299-fig2-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/80f52e2ee468/elife-101299-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/42adbcf482a5/elife-101299-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/2b4b56f4176d/elife-101299-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/b20e4644e839/elife-101299-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/87c7354db015/elife-101299-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/684c90a89132/elife-101299-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/a3e22dad0e6f/elife-101299-fig5-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/38af8f2aa601/elife-101299-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/1bf4ac49fe63/elife-101299-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/d3b3a90a1926/elife-101299-fig6-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/8b11b64a9744/elife-101299-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/4a170e04b391/elife-101299-fig7-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/05f7f4682930/elife-101299-fig7-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2390/12055005/66e1c1a4bc83/elife-101299-fig7-figsupp3.jpg

相似文献

1
The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven murine liver cancer cells.上下文依赖的表观遗传和器官发生程序决定了MYC驱动的小鼠肝癌细胞的三维与二维细胞适应性。
Elife. 2025 May 6;14:RP101299. doi: 10.7554/eLife.101299.
2
The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven murine liver cancer cells.上下文依赖性表观遗传和器官发生程序决定了MYC驱动的小鼠肝癌细胞的三维与二维细胞适应性。
Res Sq. 2025 Jan 7:rs.3.rs-4390765. doi: 10.21203/rs.3.rs-4390765/v1.
3
Distinct functions of transforming growth factor-β signaling in c-MYC driven hepatocellular carcinoma initiation and progression.转化生长因子-β信号在 c-MYC 驱动的肝细胞癌起始和进展中的不同功能。
Cell Death Dis. 2021 Feb 19;12(2):200. doi: 10.1038/s41419-021-03488-z.
4
Myelocytomatosis-Protein Arginine N-Methyltransferase 5 Axis Defines the Tumorigenesis and Immune Response in Hepatocellular Carcinoma.髓系细胞瘤蛋白精氨酸 N-甲基转移酶 5 轴定义了肝癌的肿瘤发生和免疫反应。
Hepatology. 2021 Oct;74(4):1932-1951. doi: 10.1002/hep.31864. Epub 2021 Jul 13.
5
MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state.MYC 驱动的表观遗传重编程通过诱导类似干细胞的状态促进肿瘤发生。
Nat Commun. 2018 Mar 9;9(1):1024. doi: 10.1038/s41467-018-03264-2.
6
IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.IGF2 通过表观遗传机制在肝细胞癌中上调,并且是实验模型中可操作的癌基因产物。
Gastroenterology. 2016 Dec;151(6):1192-1205. doi: 10.1053/j.gastro.2016.09.001. Epub 2016 Sep 7.
7
The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.表观遗传修饰因子JMJD6在乳腺肿瘤中扩增,并与c-Myc协同作用,增强细胞转化、肿瘤进展和转移。
Clin Epigenetics. 2016 Apr 14;8:38. doi: 10.1186/s13148-016-0205-6. eCollection 2016.
8
The Transcriptional Coactivator, ALL1-Fused Gene From Chromosome 9, Simultaneously Sustains Hypoxia Tolerance and Metabolic Advantages in Liver Cancer.转录共激活因子 ALL1-融合基因来自染色体 9,同时维持肝癌的耐缺氧和代谢优势。
Hepatology. 2021 Oct;74(4):1952-1970. doi: 10.1002/hep.31870. Epub 2021 Aug 10.
9
TSC/mTORC1 mediates mTORC2/AKT1 signaling in c-MYC-induced murine hepatocarcinogenesis via centromere protein M.TSC/mTORC1 通过着丝粒蛋白 M 介导 c-MYC 诱导的小鼠肝癌发生中的 mTORC2/AKT1 信号通路。
J Clin Invest. 2024 Sep 26;134(22):e174415. doi: 10.1172/JCI174415.
10
KMT2D-mediated H3K4me1 recruits YBX1 to facilitate triple-negative breast cancer progression through epigenetic activation of c-Myc.KMT2D 通过 H3K4me1 募集 YBX1,通过表观遗传激活 c-Myc 促进三阴性乳腺癌进展。
Clin Transl Med. 2024 Jul;14(7):e1753. doi: 10.1002/ctm2.1753.

引用本文的文献

1
From preneoplastic lesion to heterogenous tumor: recent insights into hepatoblastoma biology and therapeutic opportunities.从癌前病变到异质性肿瘤:肝母细胞瘤生物学及治疗机遇的最新见解
Mol Cancer. 2025 Jul 19;24(1):198. doi: 10.1186/s12943-025-02405-8.

本文引用的文献

1
TGF-β/SMAD canonical pathway induces the expression of transcriptional cofactor TAZ in liver cancer cells.转化生长因子-β/小 Mothers against decapentaplegic(SMAD)经典信号通路可诱导肝癌细胞中转录辅因子TAZ的表达。
Heliyon. 2023 Oct 31;9(11):e21519. doi: 10.1016/j.heliyon.2023.e21519. eCollection 2023 Nov.
2
Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastoma.高危肝母细胞瘤中癌症相关基因和化疗遗传修饰体的全基因组图谱绘制。
Nat Commun. 2023 Jul 6;14(1):4003. doi: 10.1038/s41467-023-39717-6.
3
Loss of Mettl3 enhances liver tumorigenesis by inducing hepatocyte dedifferentiation and hyperproliferation.
Mettl3 的缺失通过诱导肝细胞去分化和过度增殖促进肝癌发生。
Cell Rep. 2023 Jul 25;42(7):112704. doi: 10.1016/j.celrep.2023.112704. Epub 2023 Jun 27.
4
Interplay of hypoxia-inducible factors and oxygen therapy in cardiovascular medicine.低氧诱导因子与氧疗在心血管医学中的相互作用。
Nat Rev Cardiol. 2023 Nov;20(11):723-737. doi: 10.1038/s41569-023-00886-y. Epub 2023 Jun 12.
5
Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours.一千个肿瘤中的转录肿瘤内异质性特征。
Nature. 2023 Jun;618(7965):598-606. doi: 10.1038/s41586-023-06130-4. Epub 2023 May 31.
6
Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities.儿童癌细胞系图谱的生成与多维分析确定了新的治疗机会。
Cancer Cell. 2023 Apr 10;41(4):660-677.e7. doi: 10.1016/j.ccell.2023.03.007. Epub 2023 Mar 30.
7
METTL14 modulates glycolysis to inhibit colorectal tumorigenesis in p53-wild-type cells.METTL14 通过调节糖酵解抑制 p53 野生型细胞中的结直肠肿瘤发生。
EMBO Rep. 2023 Apr 5;24(4):e56325. doi: 10.15252/embr.202256325. Epub 2023 Feb 16.
8
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials.晚期实体瘤和急性髓系白血病中氧化磷酸化复合物 I 抑制剂的 I 期临床试验。
Nat Med. 2023 Jan;29(1):115-126. doi: 10.1038/s41591-022-02103-8. Epub 2023 Jan 19.
9
Pan-cancer analysis of tissue and single-cell HIF-pathway activation using a conserved gene signature.基于保守基因特征的泛癌症组织和单细胞 HIF 通路激活分析。
Cell Rep. 2022 Nov 15;41(7):111652. doi: 10.1016/j.celrep.2022.111652.
10
Hydroxymethylbilane synthase (aka porphobilinogen deaminase): A novel metabolic tumor suppressor gene in hepatocellular carcinoma.羟甲基胆色素原合酶(又名胆色素原脱氨酶):肝细胞癌中的一种新型代谢性肿瘤抑制基因。
J Hepatol. 2022 Oct;77(4):912-914. doi: 10.1016/j.jhep.2022.06.023. Epub 2022 Jul 5.